Health policy shapes the regulatory, financing, and organisational frameworks within which life science innovation is developed, evaluated, and delivered to patients. Pricing pressures, health technology assessment methodologies, and real-world evidence requirements are increasingly central to commercial strategy. LSF covers policy shifts across major regulatory bodies and payer systems globally.
CMS Prior Authorization Reforms Commendable, Still Needs Work, ACR Says
CMS's new rule reforming prior authorization aims to streamline processes, but the American College of Rheumatology states it does not go far enough to reduce clinician burden.
Medicare Exclusions: Avoiding Boring Mistakes That Cost Practices
Minor administrative errors and compliance oversights can lead to Medicare exclusion, severely impacting a practice's financial viability and patient access.
FDA Advisory Committee on Peptides Riddled with Conflicts of Interest
An FDA advisory committee reviewing peptide therapies for obesity included members with significant financial ties to drug manufacturers, raising concerns about impartiality.
Physician Payment Reforms: A Step, Not a Solution
Recent physician payment reforms represent a move toward value-based care, but significant structural changes are still needed to address systemic issues.
AI Scribes: Navigating Legal Risks in Clinical Documentation
AI scribes offer efficiency but introduce significant legal and ethical challenges for clinicians, particularly concerning data privacy and liability.
Accountants Urge Docs: Act Now on 2027 Tax Changes
Accountants advise European GPs and specialists to review their financial structures and pension contributions immediately, ahead of significant tax reforms anticipated in 2027.
Physician Wealth Surges Quietly, Raising Questions on Practice Models
Physician compensation has seen a substantial, quiet increase over the last decade, driven by evolving practice structures and shifts in healthcare economics.
MAHA Faces Rural Health Gaps: Infrastructure and Workforce Deficits
Microangiopathic hemolytic anemia (MAHA) presents diagnostic and management challenges in rural settings due to limited resources and specialist access.
HHS Proposes Plan to Accelerate Clinical Trial Timelines
The US Department of Health and Human Services (HHS) has outlined a strategy to expedite clinical trials, aiming to reduce development times for new therapies.